NO961685L - Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom - Google Patents

Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom

Info

Publication number
NO961685L
NO961685L NO961685A NO961685A NO961685L NO 961685 L NO961685 L NO 961685L NO 961685 A NO961685 A NO 961685A NO 961685 A NO961685 A NO 961685A NO 961685 L NO961685 L NO 961685L
Authority
NO
Norway
Prior art keywords
carriers
minimal disease
thymosin
treating hepatitis
subject
Prior art date
Application number
NO961685A
Other languages
English (en)
Other versions
NO961685D0 (no
Inventor
Bruce F Scharschmidt
John D Baxter
David L Horwitz
Original Assignee
Sciclone Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/833,468 external-priority patent/US5308833A/en
Application filed by Sciclone Pharmaceuticals filed Critical Sciclone Pharmaceuticals
Publication of NO961685D0 publication Critical patent/NO961685D0/no
Publication of NO961685L publication Critical patent/NO961685L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Minimalsykdoms hepatitt B-infeksJon hos et individ kan bekjempes ved til individet å administrere en tera- peutisk effektiv mengde av minst et peptld valgt blant gruppen thymosin o-l, et biologisk aktivt fragment av thymosin »-l og en biologisk aktiv analog av thymosin cx-1, i en farmasøytisk akseptabel bærer.
NO961685A 1992-02-06 1996-04-26 Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom NO961685L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/833,468 US5308833A (en) 1992-02-06 1992-02-06 Method for treating hepatitis B carriers with minimal disease
PCT/US1993/010343 WO1995011688A1 (en) 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease

Publications (2)

Publication Number Publication Date
NO961685D0 NO961685D0 (no) 1996-04-26
NO961685L true NO961685L (no) 1996-04-26

Family

ID=1340654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961685A NO961685L (no) 1992-02-06 1996-04-26 Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom

Country Status (5)

Country Link
EP (1) EP0728010A4 (no)
NO (1) NO961685L (no)
SG (1) SG64892A1 (no)
TW (1) TW249755B (no)
WO (1) WO1995011688A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT731710E (pt) * 1993-11-05 2003-09-30 Sciclone Pharmaceuticals Inc Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
TW224053B (no) * 1991-09-13 1994-05-21 Paul B Chretien
US5308833A (en) * 1992-02-06 1994-05-03 Sciclone Pharmaceuticals Method for treating hepatitis B carriers with minimal disease

Also Published As

Publication number Publication date
WO1995011688A1 (en) 1995-05-04
NO961685D0 (no) 1996-04-26
SG64892A1 (en) 1999-05-25
TW249755B (no) 1995-06-21
EP0728010A1 (en) 1996-08-28
EP0728010A4 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
EA199800674A1 (ru) Способ повторного лечения больных гепатитом с
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE117548T1 (de) Pharmazeutische zubereitungen zur verhütung von arzneimitteltoleranz.
LV10054A (lv) Pretvirusu antibakterials savienojums un lietosanas metode
DK0597033T3 (da) IGF-1 til forbedring af den neurale tilstand
DK0662157T3 (da) Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme
KR950701350A (ko) 부작용 감소와 동시에 인터페론을 이용한 질환의 치료방법 및 조성물(methods and compositions for the treatment of diseases with interferon while reducing side effects)
MXPA02007931A (es) Analogos de nucleosido con base monociclica modificada con carboxamidina.
RU2002130192A (ru) Способ лечения или предупреждения ожирения
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
KR960705578A (ko) 경증 질환을 가진 b형 간염 보균자의 치료방법(method for treating hepatitis b carriers with minimal disease)
NO961685L (no) Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom
HK1041215A1 (en) Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
RU2003100517A (ru) Новый интерферон для лечения рассеянного склероза
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
CA2142862A1 (en) Method for Inhibiting HIV Replication Using IL-4
MY137298A (en) Therapeutic nucleosides
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
MY109685A (en) Method for treating hepatitis b carriers with minimal disease
DK0556051T3 (da) Anvendelse af bilobalid samt derivater deraf til behandling af en infektion hos et individ og farmaceutiske præparater tilpasset denne anvendelse.
RU93033683A (ru) Способ лечения язвенной болезни двенадцатиперстной кишки
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації
HUP0202653A2 (hu) Autoimmun állapotok kezelése 1-típusú kopolimerrel és rokon kopolimerekkel
TH15542A (th) วิธีสำหรับรักษาผู้เป็นพาหะของเฮพาไททิสบี ที่มีอาการของโรคต่ำสุด